ES2133454T3 - Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles. - Google Patents

Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles.

Info

Publication number
ES2133454T3
ES2133454T3 ES94113877T ES94113877T ES2133454T3 ES 2133454 T3 ES2133454 T3 ES 2133454T3 ES 94113877 T ES94113877 T ES 94113877T ES 94113877 T ES94113877 T ES 94113877T ES 2133454 T3 ES2133454 T3 ES 2133454T3
Authority
ES
Spain
Prior art keywords
lysinates
effervescent
insoluble
mix
hardly soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94113877T
Other languages
English (en)
Inventor
Gerhard Dr Gergely
Thomas Dr Gergely
Irmgard Gergely
Stefan Dr Gergely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2133454T3 publication Critical patent/ES2133454T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/82—Acid flavourants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

LA MEZCLA EFERVESCENTE CONTIENE AL MENOS UNA SUSTANCIA ACTIVA FARMACEUTICA ACIDA, INSOLUBLE O DIFICILMENTE SOLUBLE EN FORMA DE SU SAL ALCALINA SOLUBLE O LISINATO, QUE EN UNA MEZCLA INTIMA ESTA PRESENTE CON EL COMPONENTE ALCALINO Y CON PREFERENCIA ENVUELTO CON LAS PARTICULAS DEL COMPONENTE ALCALINO DEL SISTEMA EFERVESCENTE, POR EJEMPLO BICARBONATO DE SODIO Y/O CARBONATO DE SODIO. AMBOS COMPONENTES PUEDEN TAMBIEN ESTAR PRESENTES DE FORMA PULVERIZADA FINA CON LA AYUDA DE UN AGLOMERANTE COMO GRANULADO. LA MEZCLA EFERVESCENTE CONTIENE ESPECIALMENTE SOBRE 100 PARTES DE SUSTANCIA ACTIVA AL MENOS 0,5, CON PREFERENCIA DESDE 1 HASTA 3 PARTES DE UN SURFACTANTE, ESPECIALMENTE DIOCTIL SULFOSUCINATO, Y/O AL MENOS 1, CON PREFERENCIA 3 HASTA 5 PARTES DE UN MEDIO AGLOMERANTE O MEDIO AUXILIAR DE SUSPENSION, EN PARTICULAR POLIVINIL PIRROLIDON. EL COMPONENTE ACIDO DEL SISTEMA EFERVESCENTE ESTA PASIVADO SUPERFICIALMENTE.
ES94113877T 1993-09-07 1994-09-05 Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles. Expired - Lifetime ES2133454T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH265293 1993-09-07

Publications (1)

Publication Number Publication Date
ES2133454T3 true ES2133454T3 (es) 1999-09-16

Family

ID=4238568

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94113877T Expired - Lifetime ES2133454T3 (es) 1993-09-07 1994-09-05 Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles.

Country Status (9)

Country Link
US (1) US5593693A (es)
EP (2) EP0642784B1 (es)
JP (1) JPH07223937A (es)
CN (1) CN1096279C (es)
AT (2) ATE219762T1 (es)
CA (1) CA2131515C (es)
DE (3) DE59410143D1 (es)
DK (1) DK0642784T3 (es)
ES (1) ES2133454T3 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283029B1 (it) * 1996-05-17 1998-04-03 Resa Farma Composizioni farmaceutiche a base di diclofenac
US7687542B2 (en) 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
US6974595B1 (en) 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
DE59808063D1 (de) * 1998-06-03 2003-05-28 Gergely Dr & Co Mit Alkali- bzw. Erdalkali-Ionen dotierte Zitronensäure
US6121215A (en) * 1999-08-27 2000-09-19 Phyzz, Inc. Foaming effervescent bath product
US6432450B1 (en) 1999-09-09 2002-08-13 Gerhard Gergely Effervescent granules with delayed effervescent effect
EP1082957B1 (de) * 1999-09-09 2003-04-23 Dr. Gergely & Co. Brausegranulat mit verzögerter Brausewirkung
FR2811531A1 (fr) * 2000-07-12 2002-01-18 Bionatec Produit pour le maintien d'objets decoratifs, procede de fabrication et d'utilisation dudit produit
JP2005521497A (ja) * 2002-03-25 2005-07-21 ワシントン・ユニバーシティ キメラ膵臓
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
EP3216445A1 (en) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JO3352B1 (ar) 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US7939561B2 (en) 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens
US7700125B2 (en) 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
BRPI0714423B1 (pt) 2006-07-12 2016-10-04 Purac Biochem Bv partícula grau alimentício revestida com ácido parcialmente neutralizado, produto alimentício ou bebida, método para preparação da referida partícula e uso de ácido policarboxílico
WO2013052019A1 (en) * 2011-08-19 2013-04-11 Mahmut Bilgic Production method for effervescent formulations comprising diclofenac
WO2013109222A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Formulations comprising diclofenac as the active agent
EP3037387A1 (en) * 2014-12-22 2016-06-29 Solvay SA Alkali metal bicarbonate particles with exceptional flowability

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3165572D1 (en) * 1981-10-06 1984-09-20 Gergely Gerhard Process for manufacturing effervescent granules which may be transformed, when required, into effervescent tablets
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
JPS6092378A (ja) * 1983-09-28 1985-05-23 ゲルハルト・ゲルゲリー 起泡剤およびその製造方法
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
DE3627475A1 (de) 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
DE3838431A1 (de) 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
IT1246350B (it) * 1990-07-11 1994-11-17 Eurand Int Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
CA2112663C (en) * 1991-07-01 2002-04-23 Thomas Gergely Effervescent systems using reaction doping agents
DE9300886U1 (de) * 1993-01-22 1993-05-27 Ebinger, Klaus, 5000 Köln Stabförmige Magnetometer-Sonde

Also Published As

Publication number Publication date
EP0867426A2 (de) 1998-09-30
ATE180164T1 (de) 1999-06-15
ATE219762T1 (de) 2002-07-15
EP0867426B1 (de) 2002-06-26
CN1107366A (zh) 1995-08-30
DK0642784T3 (da) 1999-11-22
CA2131515C (en) 2006-08-29
DE59408273D1 (de) 1999-06-24
JPH07223937A (ja) 1995-08-22
EP0642784A1 (de) 1995-03-15
CN1096279C (zh) 2002-12-18
DE9422239U1 (de) 1999-05-06
EP0642784B1 (de) 1999-05-19
US5593693A (en) 1997-01-14
EP0867426A3 (en) 1998-11-11
DE59410143D1 (de) 2002-08-01
CA2131515A1 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
ES2133454T3 (es) Mezcla efervescente con sales alcalinas o lisinatos de principios activos acidos, insolubles o dificilmente solubles.
SE8902288D0 (sv) Farmaceutisk komposition
CA2290504A1 (en) Tablets, and process for making tablets
CA2333869A1 (en) Mousse composition
ATE117199T1 (de) Reaktionsdotierte brausesysteme.
EP1050297A3 (en) Lotionized tissue products containing a pH balance compound for the skin
CA2389292A1 (en) Absorbent article which maintains prolonged natural skin ph
EP0678031A4 (en) TISSUE GROWTH INHIBITORS FROM TISSUE, METHODS FOR THEIR PRODUCTION AND USE THEREOF.
NO20011281L (no) Insekticid preparat
FR2666508B1 (fr) Compositions pharmaceutiques contenant des derives de furanne.
DK640587A (da) Cytostatisk virksomme anthracyclinderivater cytostatisk virksomme anthracyclinderivater
ES2090997T3 (es) Substratos activos encapsulados de manera liberable.
AU5260096A (en) Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agent containing the same as active ingredient
UA26305A (uk) Таблетка, спосіб її одержаhhя, граhулят та спосіб одержаhhя граhулята
AU5177390A (en) Pyridine derivatives and their salts, and insecticidal/acaricidal agent containing the same as active ingredient
CA2578185A1 (en) Use of 2-mercapto-pyridine n-oxide
ES8802560A1 (es) Un metodo para la preparacion de derivados estables efervescentes de acido acetilsalicilico con propiedades antihistaminicas.
SE9002495D0 (sv) Medel foer minskning av immisionsskador paa skog
JPS5344592A (en) Condensed quinazoline derivatives
FI950779A7 (fi) Homepromoottorit, jotka ovat aktiivisia glukoosin läsnäollessa

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 642784

Country of ref document: ES